Genespire Glides Into Gene Therapy Space
Sofinnova Partners Invests In Italian Biotech
Milan, Italy is a hotspot in Europe for gene therapy research, and the European VC Sofinnova Partners is backing the latest start-up aimed at metabolic and primary immunodeficiencies.
You may also be interested in...
BIO panel with Roche’s James Sabry, Spark’s Federico Mingozzi and Adaptive’s Harlan Robins imagines a world where cell and gene therapies are preferred over small molecules and antibodies.
Orchard is aiming to get its second autologous gene therapy on the market next year, with a European filing for MLD and a BLA to follow.
GlaxoSmithKline PLC's 'bubble boy' treatment has been given a positive opinion by the European Medicines Agency's advisory committee.